Rocket Lab's 17-Hour Space Force Sprint Fails to Ignite Stock as 44% Monthly Rout Deepens

Rocket Lab sets launch records and wins NASA missions, but stock drops 41-44% due to SpaceX IPO and share dilution. Earnings in August may reset the narrative.

The gap between operational excellence and market sentiment at Rocket Lab has rarely been wider. In the span of a single week, the company pulled off a record-breaking launch for the U.S. Space Force, booked three new NASA missions, and delivered its tenth satellite for Japanese client Synspective. Yet the stock closed on Friday at €72.70 — a roughly 41-44% wipeout over the past 30 days, depending on the metric, and nearly half the all-time high of €133.80 reached in May.

The VICTUS-HAZE mission for the Space Force exemplifies the contradiction. Rocket Lab executed the orbital insertion just 17 hours after receiving the official order — a speed record that underscores its responsiveness in a domain where time is the ultimate currency. That same week, NASA signed up for three Electron launches for the PolSIR and TSIS-2 scientific payloads, with flights beginning in early 2027. The Synspective constellation, meanwhile, continues to grow on schedule, with the Japanese Earth-imaging startup now operating ten satellites.

Rocket Lab’s balance sheet tells a similarly bullish story. First-quarter revenue hit a record $200 million, and the backlog stands at over $2 billion. In May, the Space Force awarded a $90 million contract for two geostationary satellites carrying the Heimdall surveillance payload — a first for Rocket Lab, which will build and operate the systems from scratch, marking its entry into the high-value GEO market.

So why is the market running for the exits? Two forces have collided to capsize the stock. The mid-June IPO of SpaceX — widely seen as a sector-defining event — sucked capital out of rival space names as investors rotated into the industry's dominant player. At the same time, Rocket Lab's management is running an active $3 billion stock sale program, a steady dilution that has spooked potential buyers. Even the company's recent inclusion in the Nasdaq-100 failed to stem the sell-off.

Technical indicators suggest the rout may be overdone. The relative strength index (RSI) has fallen to 35.3, a level that often signals oversold conditions. On a year-to-date basis, the stock still clings to a roughly 12% gain, but the speed of the decline has erased most of the 2025 advance.

All eyes are now on the second-quarter earnings report due in August. Management has guided for revenue of up to $240 million, and hitting that target could redirect investor attention from macro headwinds back to the company’s fundamental strengths. Beyond the numbers, the key catalyst remains the Neutron rocket, a medium-lift vehicle designed to compete directly with SpaceX's Falcon line. Construction of the launch pad is already in full swing, and a first flight is expected before the end of the year.

For now, Rocket Lab is outrunning its own stock — a record-breaking marathon that the market has decided to ignore. Whether the August earnings call can reset the narrative remains the critical question.